Tag: grant
-
Vaccine Combo Produces Ricin, Anthrax Antibodies
29 December 2014. Tests of a vaccine to prevent ricin and anthrax poisoning shows it produces long-lasting antibodies against both toxins, making a single vaccine against both bioterror agents more feasible. Results of a study by biotechnology company Soligenix Inc. in Princeton, New Jersey are reported in the January 2015 issue of the journal Vaccine…
-
University Prof to Commercialize 3-D Printed Cell Platforms
15 December 2014. A biomedical engineer at Louisiana Tech University in Ruston plans to develop a commercial platform for three-dimensional printing of artificial cells in research, education, and industrial applications. Mark DeCoster, an engineering faculty member at Louisiana Tech, received a $50,000 National Science Foundation I-Corps grant to further develop the idea into a marketable…
-
Yale Univ, Organovo to Develop 3-D Print Transplant Tissue
3 December 2014. Yale University and Organovo Inc. in San Diego are collaborating on development of synthetic tissue produced on three-dimensional printers for research on transplants in humans. Financial details of the partnership were not disclosed, but Yale and Organovo say the project is funded by the Methuselah Foundation. Organovo designs and produces human tissue…
-
NIH Grant Funds Review for New Brain Cancer Diagnostics
2 December 2014. National Cancer Institute, an agency of National Institutes of Health (NIH), awarded a grant to HealthTell Inc. to validate the company’s technology for development of a simple test to diagnose brain cancers, including glioblastoma multiforme, an aggressive and malignant form of the disease. The $225,000 grant to HealthTell funds an early-stage study…
-
Gates Foundation Funds Malaria Vaccine Development
3 November 2014. The Bill and Melinda Gates Foundation is awarding $156 million for a new type of malaria vaccine that prevents infection and transmission of the disease. Bill Gates, co-chair of the foundation, announced the grant to the Path Malaria Vaccine Initiative yesterday during keynote remarks at the American Society of Tropical Medicine and Hygiene’s…
-
Clinical Trial Proposals Sought for ALS Treatments
22 October 2014. A group of U.S. organizations promoting research on therapies for amyotrophic lateral sclerosis or ALS are seeking proposals from academic-industry research teams for intermediate stage clinical trials to test treatment candidates for the disease. The organizations — ALS Association, ALS Accelerated Therapeutics or ALS ACT, and Northeast ALS Consortium — plan to…
-
Project Developing DNA Antibodies for Infectious Diseases
21 October 2014. The biotechnology company Inovio Pharmaceuticals Inc. and partners are developing synthetic antibodies based on DNA that generate an immune reaction to prevent infectious diseases, a project funded by Department of Defense Advanced Research Projects Agency or DARPA. The $12.2 million DARPA grant is supporting the work of Inovia, in Plymouth Meeting, Pennsylvania,…
-
Experimental Drug Kills Myeloma Cells in Lab, Trial Planned
13 October 2014. Medical researchers at Imperial College London in the U.K. developed an experimental drug that in lab and animal tests kills multiple myeloma cancer cells without the toxic side effects of other cancer drugs. The team led by Imperial medical professor Guido Franzoso published its findings today in the journal Cancer Cell, with…
-
Chip Emulates Human Airway Muscles to Test Asthma Treatments
24 September 2014. Biomedical engineers at Harvard University developed a model of human airway muscles on a miniaturized chip that emulates their actions during an asthma attack. The senior author of the paper describing the airway muscles chip, Kevin Kit Parker, is also a recipient of a new National Institutes of Health grant to develop…
-
Small Business Grant Funds Point-of-Care Sickle Cell Test
22 September 2014. A Cambridge, Massachusetts diagnostics company received a Small Business Innovation Research (SBIR) grant to develop a simple point-of-care test for sickle cell disease, a genetic blood disorder affecting a large percentage of people of African origin. The $225,000 grant from National Institutes of Health’s SBIR program to Daktari Diagnostics will support development…